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early-onset BCC. This is similar to the
1.3-fold increased odds of BCC with
tetracycline use reported by Kaae et al.
Interestingly, that study also reported a
2-fold increased risk of BCC with
isotretinoin use, supporting Robinson’s
hypothesis that acne as an indication
may increase BCC risk as well. Further
studies focused on acne patients may
resolve whether the increased BCC risk
observed is due to the medication or the
underlying pathology.
Conclusion
Robinson et al. (2013) report their
findings about the association between
photosensitizing medication use and
the risk of NMSC, in particular the
association of tetracyclines with BCC
risk and diuretics with SCC risk. This
clinical relevance of these associations
is still uncertain but it seems reasonable
that patients prescribed these medi-
cations should be counseled regarding
sun protection. This information needs
to be disseminated to our colleagues in
primary care and internal medicine, as
they are the primary prescribers of these
medications. Dermatologists should also
counsel our acne patients regarding sun
protection with long-term tetracycline
use. Taking a history of photosensitiz-
ing medication use should also become
part of screening for skin cancer risk,
along with a lifetime history of sun
exposure, Fitzpatrick skin type, and
exposure to tanning beds. Future
studies in this area, dedicated to speci-
fic medications and exposure patterns,
will validate the reported associations
and suggest additional steps toward the
detection and ultimate prevention of
skin cancer.
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Clinical Implications
 Robinson et al. report a population-based case–control study that found
an increased risk of basal cell carcinoma with tetracycline use and of
squamous cell carcinoma with diuretic use.
 It seems reasonable that patients prescribed these medications should be
counseled regarding sunlight protection.
 Taking a history of photosensitizing medication use should be part of
screening for skin cancer risk.
Phacomatosis Pigmentokeratotica Is a
‘‘Pseudodidymosis’’
Rudolf Happle1
In phacomatosis pigmentokeratotica, papular nevus spilus coexists with nevus
sebaceus. The disorder was thought to be a didymosis with early postzygotic
recombination. In this issue, however, Groesser and co-workers provide a new
concept. Both nevi originate from a single heterozygous HRAS mutation in a
pluripotent progenitor cell. This new understanding has implications for other
proposed examples of didymosis in humans.
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Phacomatosis pigmentokeratotica (PPK)
is characterized by the coexistence of
nevus sebaceus and papular nevus spilus
(Figure 1). The disorder has so far been
considered to represent an example of
twin spotting or didymosis, which is why
it has also been called ‘‘didymosis spilo-
sebacea’’ (Happle, 2010). These binary
nevi are often associated with various
extracutaneous defects. Seventeen years
ago, we proposed the hypothesis that the
disorder represents a nonallelic twin-
spot phenomenon (Happle et al., 1996).
Accordingly, the two nevi would have
originated from an early event of
postzygotic recombination, resulting in
a loss of heterozygosity and, thus, be
homozygous at either of the two loci
that were situated in different regions on
a pair of homologous chromosomes
(Happle, 1999). Thus far, this etiological
concept had been accepted widely
(Boente et al., 2000; Martı´nez-Menchon
et al., 2005; Bouthors et al., 2006;
Gruson et al., 2006; Oh et al, 2012),
although molecular proof was lacking.
In the present issue, however,
Groesser et al. (2013) present
molecular findings that disprove the
twin-spot hypothesis. From an analysis
of six patients affected with PPK, they
provide convincing evidence that both
the sebaceous nevus and the papular
nevus spilus originate from the same
postzygotic HRAS mutation, being
present in a heterozygous state. Hence,
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in this complex disorder, the concept of
nonallelic didymosis is untenable.
The discovery that PPK is caused by a
postzygotic-activating HRAS mutation
present in a multipotent progenitor cell
has important implications for future
research on binary mosaic genoderma-
toses. This is especially true for some of
the other proposed examples of nonal-
lelic twin spotting, such as phacomato-
sis cesioflammea and phacomatosis
spilorosea (Happle, 2005). I fully agree
with Dr. Groesser and his co-workers
that such binary skin disorders may
likewise turn out to be caused by a
single pleiotropic mutation present in a
heterozygous state. In contrast, we
should bear in mind that in Drosophila
melanogaster several examples of nona-
llelic didymosis have been thoroughly
studied (Stern, 1936; Graf et al., 1984;
Spano´ et al., 2001). Therefore, it seems
reasonable to assume that nonallelic
didymosis may occur sometimes in
mammals, including humans.
Moreover, it seems still likely that the
concept of allelic didymosis as proposed
for the paired occurrence of nevus
flammeus and nevus anemicus
(Happle, 1999), mixed vascular nevus
syndrome (Ruggieri et al., 2012), and
cutis tricolor (Lionetti et al., 2010) will
be corroborated by molecular studies.
This view is supported by the fact that
allelic didymosis is a well-established
phenomenon in both plants and animals
(Harrison and Carpenter, 1977;
Vig et al., 1982; Griffin et al., 2009).
Groesser et al. (2013) infer that in
isolated Schimmelpenning syndrome,
the underlying mosaic HRAS mutation
is lost in the melanocytic progenitor
cells. Conversely, in isolated papular
nevus spilus syndrome (Happle, 2010),
the mosaic HRAS mutation would be
lost in the epithelial progenitor cells. As
the two syndromes occur together rather
often in the form of PPK, this binary
disorder may today be categorized as a
‘‘pseudodidymosis.’’
Accordingly, PPK can now be
taken as a clinical variant of the
Schimmelpenning syndrome (Groesser
et al., 2012), but with the same
justification that it may also be
categorized as a variation of papular
nevus spilus syndrome. Apparently,
the extracutaneous abnormalities asso-
ciated with either of the two nevi show
remarkable differences. The neuro-
logical defects of the Schimmelpenning
syndrome include mental deficiency,
seizures, and hemiparesis, whereas
papular nevus spilus syndrome tends
to be associated with segmental
hyperhidrosis and dysesthesia. Future
studies may show whether the
presence of such dichotomous noso-
logical relations can be documented in
more patients affected with PPK or with
one of its melanocytic or epithelial
components.
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Figure 1. A binary dermatosis, but no didymosis: nevus sebaceus and papular nevus spilus involving
either side of the body in a 10-year-old girl. (a) Frontal view. (b) Dorsal view. (Hermes et al., 1994;
reprinted with permission from S. Karger AG, Basel, Switzerland).
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Innate Immunity Stimulates
Permeability Barrier Homeostasis
Kenneth R. Feingold1
A key function of the skin is to provide a permeability barrier to restrict the
movement of water, electrolytes, and other small molecules between the outside
environment and the internal milieu. Following disruption of the permeability
barrier, there is a rapid restoration of barrier function, and one of the key
signals initiating this repair response is a decrease in the concentration of
calcium in the outer epidermis. In this issue, Borkowski et al. present evidence
showing that activation of Toll receptor 3 by double-stranded RNA may be
another pathway for activation of permeability barrier repair. These results
provide further evidence for a link between innate immunity and the permeability
barrier.
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An important function of the skin is to
form a barrier between an outside hos-
tile environment and the internal milieu.
One key barrier function is to restrict
the movement of water, electrolytes, and
other small compounds, that is, the
permeability barrier. Without a compe-
tent permeability barrier, life outside of
the sea would be impossible. Recent
studies have linked abnormalities in
permeability barrier function to the
development and progression of com-
mon skin disorders, including atopic
dermatitis and psoriasis (Wolf and
Wolf, 2012; Wolf et al., 2012).
The permeability barrier is mediated
by lipid-enriched lamellar membranes
located in the extracellular spaces of
the stratum corneum (Feingold, 2007).
The membranes contain ceramides,
cholesterol, and free fatty acids predomi-
nantly. These lipids are delivered to the
stratum corneum through the exocytosis
of lamellar bodies from stratum gra-
nulosum cells (Feingold, 2007). In turn,
the lamellar bodies contain glucosylcer-
amides, sphingomyelin, phospholipids,
and cholesterol. To form functional
lamellar membranes, the glucosylcera-
mides and sphingomyelin are converted
to ceramides, a process catalyzed by
the enzymes beta-glucocerebrosidase
and acid sphingomyelinase, and the
phospholipids are converted to free
fatty acids, a process catalyzed by
PLA2 (Feingold, 2007). The synthesis of
lamellar bodies by keratinocytes requires
a sufficient pool of cholesterol, sphing-
olipids, and phospholipids. Fatty acids
are required for the synthesis of
phospholipids and sphingolipids, and
they are derived from either de novo
synthesis by keratinocytes and/or uptake
of exogenous fatty acids by keratinocytes
(Feingold, 2007). Cholesterol may also
be synthesized in keratinocytes and/or
transported into keratinocytes by several
uptake pathways (Feingold, 2007). The
mechanism by which phospholipids
and cholesterol are incorporated into
lamellar bodies is not known, but
recent studies have demonstrated that
the transport of glucosylceramides into
lamellar bodies is mediated by ABCA12
(Feingold, 2007).
Following disruption of the perme-
ability barrier, there is a rapid restora-
tion of barrier function (Feingold, 2007).
A number of responses occur in the
underlying epidermis that facilitate this
repair process, including: (1) an almost
immediate secretion of a pre-formed
pool of lamellar bodies, (2) increased
lipid synthesis, (3) an increase in
lipoprotein receptors and fatty acid
transport proteins that facilitate the
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